Neuroimaging Biomarkers

IXICO are experts in neuroimaging methods being used in enrolment for clinical trials, to monitor safety and measure the effectiveness of new therapies. Since 2004, we have analysed over 100,000 brain scans and accredited over 2,000 clinical sites around the world. Our work with international commercial, clinical and academic partners means that we are at the forefront of the industry in developing and validating unique new neuroimaging methods and image analysis techniques. Our aim is to provide more accurate and richer brain structural and functional information.